RIPE-KG · Version 1.1.0 · Resource
ripekg:evidence-aggregation/RIPEA4F5D57083F3F36E5
https://w3id.org/ripe/ripe-kg/evidence-aggregation/RIPEA4F5D57083F3F36E5
| Subject | Predicate | Object |
|---|---|---|
ripekg:evaluation/RIPEA4F5D57083F3F36E5 |
prov:wasInformedBy |
ripekg:evidence-aggregation/RIPEA4F5D57083F3F36E5 |
ripekg:evidence-aggregation/RIPEA4F5D57083F3F36E5 |
rdf:type |
rdfs:Resource |
ripekg:evidence-aggregation/RIPEA4F5D57083F3F36E5 |
rdf:type |
owl:Thing |
ripekg:evidence-aggregation/RIPEA4F5D57083F3F36E5 |
rdf:type |
ripe:EvidenceAggregationEvidence aggregation |
ripekg:evidence-aggregation/RIPEA4F5D57083F3F36E5 |
rdf:type |
tido:Activity |
ripekg:evidence-aggregation/RIPEA4F5D57083F3F36E5 |
prov:startedAtTime |
2025-11-16T19:40:04.675617Z |
ripekg:evidence-aggregation/RIPEA4F5D57083F3F36E5 |
prov:wasAssociatedWith |
ripekg:automated-agent/inspect-ai/1.0.0INSPECT-AI 1.0.0 |
ripekg:evidence-aggregation/RIPEA4F5D57083F3F36E5 |
prov:wasAssociatedWith |
ripekg:automated-agent/inspect-ai/1.0.0INSPECT-AI |
ripekg:evidence-aggregation/RIPEA4F5D57083F3F36E5 |
tido:contributesTo |
ripekg:research-integrity-assessment/RIPEA4F5D57083F3F36E5 |
ripekg:expression-of-concern/28452Magnesium-Zinc-Calcium-Vitamin D Co-supplementation Improves Hormonal Profiles, Biomarkers of Inflammation and Oxidative Stress in Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA4F5D57083F3F36E5 |
ripekg:peer-comment/RIPEA4F5D57083F3F36E5-1 |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA4F5D57083F3F36E5 |
ripekg:peer-comment/RIPEA4F5D57083F3F36E5-2 |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA4F5D57083F3F36E5 |
ripekg:publication-details/RIPEA4F5D57083F3F36E5RETRACTED ARTICLE: Magnesium-Zinc-Calcium-Vitamin D Co-supplementation Improves Hormonal Profiles, Biomarkers of Inflammation and Oxidative Stress in Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA4F5D57083F3F36E5 |
ripekg:registry-evidence/RIPEA4F5D57083F3F36E5 |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA4F5D57083F3F36E5 |
ripekg:retraction-notice/28452Magnesium-Zinc-Calcium-Vitamin D Co-supplementation Improves Hormonal Profiles, Biomarkers of Inflammation and Oxidative Stress in Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA4F5D57083F3F36E5 |
ripekg:retraction-notice/28454The Effect of Zinc Supplementation on Expressed Levels of Peroxisome Proliferator-Activated Receptor Gamma and Glucose Transporter Type 1 Genes in Newborns of Women with Gestational Diabetes Mellitus |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA4F5D57083F3F36E5 |
ripekg:retraction-notice/28465Effects of Selenium Supplementation on Gene Expression Levels of Inflammatory Cytokines and Vascular Endothelial Growth Factor in Patients with Gestational Diabetes |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA4F5D57083F3F36E5 |
ripekg:retraction-notice/28467The effects of magnesium and vitamin E co-supplementation on parameters of glucose homeostasis and lipid profiles in patients with gestational diabetes |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA4F5D57083F3F36E5 |
ripekg:retraction-notice/40895The Effect of Zinc Supplementation on Expressed Levels of Peroxisome Proliferator-Activated Receptor Gamma and Glucose Transporter Type 1 Genes in Newborns of Women with Gestational Diabetes Mellitus |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA4F5D57083F3F36E5 |
ripekg:retraction-notice/40898Magnesium-Zinc-Calcium-Vitamin D Co-supplementation Improves Hormonal Profiles, Biomarkers of Inflammation and Oxidative Stress in Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA4F5D57083F3F36E5 |
ripekg:retraction-notice/43692The effects of omega-3 fatty acids from flaxseed oil on genetic and metabolic profiles in patients with gestational diabetes mellitus: a randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA4F5D57083F3F36E5 |
ripekg:retraction-notice/43694The effects of synbiotic supplementation on markers of insulin metabolism and lipid profiles in gestational diabetes: a randomised, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA4F5D57083F3F36E5 |
ripekg:retraction-notice/43979Calcium plus vitamin D supplementation influences biomarkers of inflammation and oxidative stress in overweight and vitamin D-deficient women with polycystic ovary syndrome: A randomized double-blind placebo-controlled clinical trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA4F5D57083F3F36E5 |
ripekg:retraction-notice/43980The effects of coenzyme Q10 supplementation on glucose metabolism and lipid profiles in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA4F5D57083F3F36E5 |
ripekg:retraction-notice/43982Oral carnitine supplementation reduces body weight and insulin resistance in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA4F5D57083F3F36E5 |
ripekg:retraction-notice/43984Comparison of myo-inositol and metformin on clinical, metabolic and genetic parameters in polycystic ovary syndrome: A randomized controlled clinical trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA4F5D57083F3F36E5 |
ripekg:retraction-notice/53090The effects of coenzyme Q10 supplementation on gene expression related to insulin, lipid and inflammation in patients with polycystic ovary syndrome |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA4F5D57083F3F36E5 |
ripekg:retraction-notice/53693Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA4F5D57083F3F36E5 |
ripekg:retraction-notice/54767Probiotic supplementation and the effects on weight loss, glycaemia and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA4F5D57083F3F36E5 |
ripekg:retraction-notice/58213The effects of probiotic supplementation on biomarkers of inflammation, oxidative stress and pregnancy outcomes in gestational diabetes |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA4F5D57083F3F36E5 |
ripekg:retraction-notice/58214The effects of probiotic supplementation on biomarkers of inflammation, oxidative stress and pregnancy outcomes in gestational diabetes |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA4F5D57083F3F36E5 |
ripekg:retraction-notice/67044Effect of daily consumption of probiotic yoghurt on lipid profiles in pregnant women: a randomized controlled clinical trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA4F5D57083F3F36E5 |
ripekg:retraction-notice/67046Effect of multivitamin versus multivitamin-mineral supplementation on metabolic profiles and biomarkers of oxidative stress in pregnant women: a double-blind randomized clinical trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA4F5D57083F3F36E5 |
ripekg:retraction-notice/67047The favorable effects of garlic intake on metabolic profiles, hs-CRP, biomarkers of oxidative stress and pregnancy outcomes in pregnant women at risk for pre-eclampsia: randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA4F5D57083F3F36E5 |
ripekg:retraction-notice/67050Omega-3 fatty acid supplementation affects pregnancy outcomes in gestational diabetes: a randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA4F5D57083F3F36E5 |
ripekg:retraction-notice/67052The effect of zinc and vitamin E cosupplementation on metabolic status and its related gene expression in patients with gestational diabetes |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA4F5D57083F3F36E5 |
ripekg:retraction-notice/67323Effects of synbiotic food consumption on metabolic status of diabetic patients: a double-blind randomized cross-over controlled clinical trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA4F5D57083F3F36E5 |
ripekg:retraction-notice/67324Effects of omega-3 fatty acid supplementation on insulin metabolism and lipid profiles in gestational diabetes: Randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA4F5D57083F3F36E5 |
ripekg:retraction-notice/67383The effects of vitamin D and probiotic co-supplementation on glucose homeostasis, inflammation, oxidative stress and pregnancy outcomes in gestational diabetes: A randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA4F5D57083F3F36E5 |
ripekg:retraction-notice/67384Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA4F5D57083F3F36E5 |
ripekg:retraction-notice/67433Clinical and metabolic response to probiotic administration in people with Parkinson's disease: A randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA4F5D57083F3F36E5 |
ripekg:retraction-notice/67435Clinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA4F5D57083F3F36E5 |
ripekg:retraction-notice/67436Metabolic response to omega-3 fatty acid supplementation in patients with diabetic nephropathy: A randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA4F5D57083F3F36E5 |
ripekg:retraction-notice/67437The effects of probiotic and selenium co-supplementation on mental health parameters and metabolic profiles in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA4F5D57083F3F36E5 |
ripekg:retraction-notice/67438Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA4F5D57083F3F36E5 |
ripekg:retraction-notice/67440The effects of vitamin E supplementation on endometrial thickness, and gene expression of vascular endothelial growth factor and inflammatory cytokines among women with implantation failure |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA4F5D57083F3F36E5 |
ripekg:retraction-notice/67441The Effects of Probiotic Supplementation on Gene Expression Related to Inflammation, Insulin, and Lipids in Patients With Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA4F5D57083F3F36E5 |
ripekg:retraction-notice/67442The Effects of Coenzyme Q10 Supplementation on Glucose Metabolism, Lipid Profiles, Inflammation, and Oxidative Stress in Patients With Diabetic Nephropathy: A Randomized, Double-Blind, Placebo-Controlled Trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA4F5D57083F3F36E5 |
ripekg:retraction-notice/67443The effects of fish oil omega-3 fatty acid supplementation on mental health parameters and metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA4F5D57083F3F36E5 |
ripekg:retraction-notice/67444Magnesium-zinc-calcium-vitamin D co-supplementation improves glycemic control and markers of cardiometabolic risk in gestational diabetes: a randomized, double-blind, placebo-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA4F5D57083F3F36E5 |
ripekg:study-design-evidence/RIPEA4F5D57083F3F36E5 |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA4F5D57083F3F36E5 |